- By insider
CEO, President and Director of Innovus Pharmaceuticals Inc (30-Year Financial, Insider Trades) Maureen Hewitt (insider trades) bought 9,350 shares of INNV on 03/12/2021 at an average price of $26.62 a share. The total cost of this purchase was $248,897.
Innovus Pharmaceuticals Inc is a pharmaceutical company engaged in the commercialization, licensing, and development of prescription and non-prescription medicine and consumer care products. Innovus Pharmaceuticals Inc has a market cap of $71.872 million; its shares were traded at around $26.000000 .
CEO Recent Trades:
-
CEO, President and Director Maureen Hewitt bought 9,350 shares of INNV stock on 03/12/2021 at the average price of $26.62. The price of the stock has decreased by 2.33% since.
Directors and Officers Recent Trades:
-
Director Edward Moore Jr. Kennedy bought 23,000 shares of INNV stock on 03/08/2021 at the average price of $21. The price of the stock has increased by 23.81% since.
For the complete insider trading history of INNV, click here
.This article first appeared on GuruFocus.